Filed: 5/7/2024ACC: 0001104659-24-058027
📋 What this filing means
WUXI APPTEC CO., LTD. filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $29.40M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$29.40M
Total AUM (reported)
12.16M
Total Shares
Allocation by class
COM$18.24M62.1%
ADS$11.15M37.9%
Portfolio Concentration
Top 3$29.40M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 12.16M
Sole
Full voting authority
12.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
LYELL IMMUNOPHARMA INC
SOLEShares8.18M
TypeSH
Market value$18.24M
62.06%
Sole
8.18M
Shared
0.00
None
0.00
ADAGENE INC
SOLEShares3.98M
TypeSH
Market value$11.15M
37.94%
Sole
3.98M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LYELL IMMUNOPHARMA INCSOLE | COM | 8.18M | SH | $18.24M 62.06% | 8.18M | 0.00 | 0.00 |
ADAGENE INCSOLE | ADS | 3.98M | SH | $11.15M 37.94% | 3.98M | 0.00 | 0.00 |